Mesa Laboratories, Inc.
corporate_fare Company Profile
Mesa Laboratories, Inc. (NASDAQ:MLAB) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 16 items for MLAB at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-09, rated 7/10. Across its 16 most recent items scored 7 or higher, the top rating is 8/10, with 4 rated 8 or above. Recent SEC coverage for MLAB spans 8-K, 10-Q, 4, 10-K.
Recent high-impact activity:
- Mesa Labs Posts 75c Q2 EPS as Operating Income Jumps 78%
- Mesa Labs Issues First-Ever FY27 Guidance: $250-255M Revenue, $66-68M Adjusted EBITDA
- Mesa Labs Q2 Operating Income Jumps 78% to $8.4M; Board Authorizes New $40M Buyback
- Mesa Labs Restructures Clinical Genomics, Cuts 40 Jobs to Save $9.3M Annually
- Mesa Labs Cuts 6% of Workforce, Targets $5M Net Annual Savings
Financial Snapshot
Short Interest & Short Volume
4.68 days to coverFINRA reported short interest of 377,163 shares in MLAB as of the October 30, 2026 settlement, a 3.4% decrease from the prior period — about 4.7 days to cover at its recent average daily volume. On November 20, 2026, 69.9% of MLAB volume reported to FINRA trade-reporting facilities was marked short.
Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.